Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 9 de 9
Filter
Add more filters











Publication year range
1.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-801799

ABSTRACT

Objective: To observe the effect and mechanism of modified Buzhong Yiqi Tang and pursed-lips breathing (PLB) on serum tumor necrosis factor-alpha (TNF-α), interleukin-8 (IL-8), IL-6, IL-1β and serum cystatin C (Cys-C) in patients of chronic obstructive pulmonary disease (COPD) at the stable stage. Method: Totally 120 cases of COPD treated at Affiliated Hospital of Jiangxi University of Traditional Chinese Medicine from September 2017 to March 2018 conformed to the inclusion criteria, and were randomly divided into treatment group (60 cases) and control group (60 cases). Cases of control group received Tiotropium (18 μg/time, qd). In addition to the therapy of control group, cases of treatment group were also given Buzhong Yiqi Tang and PLB. Both groups were treated for 6 months. Percent of forced expiratory volume in one second in predicted value (FEV1%), ratio of FEV1 to forced vital capacity (FEV1/FVC), six-minute walk distance (6MWD),TNF-α, IL-8, IL-6, IL-1β and Cys-C were compared between both groups. Result: After treatment, the clinical efficacy rate of observation group was 93.33%, which was evidently higher than 86.67%of control group (Pa,IL-8, IL-6,IL-1β, Cys-C but increases in FEV1%, FEV1/FVC (Pa, IL-8, IL-6, IL-1β, Cys-C but increases in FEV1%, FEV1/FVC (PConclusion: Buzhong Yiqi Tang and PLB has an anti-inflammatory effect on COPD by reducing levels of inflammation cytokines TNF-α, IL-8,IL-6, IL-1β and chronic inflammation markers serum Cys-C and inflammatory reaction, and alleviating airflow obstruction, promoting the levels of FEV1%, FEV1/FVC, pulmonary function control inflammatory factors, so as to improve pulmonary function and the quality of life in patients with COPD.

2.
Oncol Rep ; 36(3): 1739-47, 2016 Sep.
Article in English | MEDLINE | ID: mdl-27461876

ABSTRACT

In association studies, the combined effects of single nucleotide polymorphism (SNP)-SNP interactions and the problem of imbalanced data between cases and controls are frequently ignored. In the present study, we used an improved multifactor dimensionality reduction (MDR) approach namely MDR-ER to detect the high order SNP­SNP interaction in an imbalanced breast cancer data set containing seven SNPs of chemokine CXCL12/CXCR4 pathway genes. Most individual SNPs were not significantly associated with breast cancer. After MDR­ER analysis, six significant SNP­SNP interaction models with seven genes (highest cross­validation consistency, 10; classification error rates, 41.3­21.0; and prediction error rates, 47.4­55.3) were identified. CD4 and VEGFA genes were associated in a 2­loci interaction model (classification error rate, 41.3; prediction error rate, 47.5; odds ratio (OR), 2.069; 95% bootstrap CI, 1.40­2.90; P=1.71E­04) and it also appeared in all the best 2­7­loci models. When the loci number increased, the classification error rates and P­values decreased. The powers in 2­7­loci in all models were >0.9. The minimum classification error rate of the MDR­ER­generated model was shown with the 7­loci interaction model (classification error rate, 21.0; OR=15.282; 95% bootstrap CI, 9.54­23.87; P=4.03E­31). In the epistasis network analysis, the overall effect with breast cancer susceptibility was identified and the SNP order of impact on breast cancer was identified as follows: CD4 = VEGFA > KITLG > CXCL12 > CCR7 = MMP2 > CXCR4. In conclusion, the MDR­ER can effectively and correctly identify the best SNP­SNP interaction models in an imbalanced data set for breast cancer cases.


Subject(s)
Breast Neoplasms/genetics , Chemokine CXCL12/genetics , Multifactor Dimensionality Reduction/methods , Polymorphism, Single Nucleotide/genetics , Receptors, CXCR4/genetics , Algorithms , Epistasis, Genetic/genetics , Female , Genetic Predisposition to Disease/genetics , Humans , Models, Genetic
3.
Chinese Journal of Epidemiology ; (12): 385-388, 2013.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-318392

ABSTRACT

Objective To assess the impact of tea consumption on the risk of osteoporotic hip fractures.Methods Between January 2008 and June 2012,581 (148 males,433 females) incident cases of hip fractures were enrolled from four hospitals in Guangdong province,with 581 sex-and age-matched (± 3 years) controls from either hospitals or communities.Face-to-face interviews wer conducted to collect data pertaining to tea drinking and various covariates.Results Results from univariate conditional logistic analyses showed that an inverse association was observed in tea drinking and hip fracture risk.Longer time,greater frequency and dosage of tea consumption were dose-dependently associated with lower risk of hip fractures (P-trend <0.05).Compared to non drinkers,the odd ratios related to regular tea drinkers,subgroups with different length,frequency,dosage,type of tea consumption were ranged between 0.54 and 0.74 (all P<0.05).After adjustment for factors as age,daily energy intake,BMI,education levels,passive smoking,calcium supplement and physical activity,the dose-dependent associations among above said factors still remained significant.However,the strength of the association lowered slightly.The beneficial effect of tea was significant only in men but not in women.Similar effects were found in subjects with different education levels.Conclusion Regular tea drinking habit might decrease the risk of osteoporotic hip fractures in the elderly males.

4.
Jpn J Clin Oncol ; 42(8): 711-20, 2012 Aug.
Article in English | MEDLINE | ID: mdl-22645150

ABSTRACT

OBJECTIVE: The value of postmastectomy radiation therapy for breast cancer patients with T1-2 tumor and one to three positive nodes remains controversial. The purpose of this retrospective study was to compare the clinical outcomes of breast cancer patients with T1-2 and one to three positive nodes with and without postmastectomy radiation therapy. METHODS: Between May 1990 and June 2008, of 318 breast cancer patients with T1-2 and one to three positive nodes who had undergone modified radical mastectomy, 163 received postmastectomy radiation therapy and 155 did not. The clinico-pathologic characteristics were analyzed for clinical outcomes including loco-regional recurrence, distant metastasis, disease-free survival and overall survival. RESULTS: During the median follow-up period of 102 months, the clinical outcomes in postmastectomy radiation therapy versus no-postmastectomy radiation therapy groups were as follows: loco-regional recurrence rate (3.1 versus 11.0%, P= 0.006); distant metastasis rate (20.9 versus 27.7%, P= 0.152); 10-year disease-free survival rate (73.8 versus 61.3%, P= 0.001); and 10-year overall survival rate (82.1 versus 76.1%, P= 0.239). Through a multivariate analysis, a positive nodal ratio of ≥25% (hazard ratio= 4.571, P= 0.003) and positive lymphovascular invasion (hazard ratio= 2.738, P= 0.028) were found to be independent poor prognostic predictors of loco-regional recurrence. The reduction in loco-regional recurrence (hazard ratio= 0.208, P= 0.004) by postmastectomy radiation therapy was found to be significant. CONCLUSIONS: On the basis of our results, postmastectomy radiation therapy is highly recommended for breast cancer patients with T1-2 and one to three positive nodes, especially for high-risk subgroups with a positive nodal ratio of ≥25% and positive lymphovascular invasion, not only for reducing loco-regional recurrence but also for improving disease-free survival.


Subject(s)
Breast Neoplasms/radiotherapy , Radiotherapy, Adjuvant , Adult , Aged , Breast Neoplasms/mortality , Breast Neoplasms/pathology , Breast Neoplasms/surgery , Combined Modality Therapy , Disease-Free Survival , Female , Humans , Lymphatic Metastasis , Mastectomy , Middle Aged , Neoplasm Metastasis , Recurrence , Retrospective Studies , Treatment Outcome
5.
Anticancer Res ; 29(8): 3131-8, 2009 Aug.
Article in English | MEDLINE | ID: mdl-19661326

ABSTRACT

BACKGROUND: Tumor hypoxia promotes cancer progression. Matrix metalloproteinases (MMPs) are required for breast cancer cell invasion. MATERIALS AND METHODS: The effect of cobalt chloride (CoCl(2))-stimulated hypoxia on invasion potential and the expression of MMPs and tissue inhibitors of metalloproteinases (TIMPs) were investigated in four breast cancer cell lines, derived from primary sites (HCC1395 and HCC1937) and metastatic sites (MCF-7 and MDA-MB-231). RESULTS: CoCl(2)-induced hypoxia induced HIF-1alpha protein expression in all four cell lines. Hypoxia significantly increased the invasiveness of HCC1395 cells, which did not correlate with a change of any one MMP. Constitutive MMP expression was different between primary and metastatic breast cancer cells. MMP-2 and MMP-9 measured by RT-PCR and zymography were notably expressed in primary cancer cells but not apparent in metastatic ones. MMP-7 was also highly expressed in primary cancer cells. Hypoxia increased the expression of MMP-1, -10 and -13 in metastatic breast cancer cells, whereas only MMP-13 was up-regulated in primary HCC1937 cells by hypoxic stimulation. TIMPs were not altered by hypoxia, except for TIMP-4 which was down-regulated in MDA-MB-231 cells. CONCLUSION: This study demonstrated a cell line-specific effect of hypoxia on invasive potential and differential expression of constitutive MMPs in primary versus metastatic breast cancer cells, i.e. primary cancer cells expressed a wider range of MMPs, in particular MMP-2, -7 and -9, than the metastatic ones. The data suggest that MMPs play no crucial roles in hypoxia-induced tumor progression in primary breast cancer cells.


Subject(s)
Adenocarcinoma/enzymology , Antimutagenic Agents/pharmacology , Breast Neoplasms/enzymology , Cobalt/pharmacology , Hypoxia/drug therapy , Matrix Metalloproteinases/metabolism , Tissue Inhibitor of Metalloproteinases/metabolism , Adenocarcinoma/drug therapy , Adenocarcinoma/secondary , Biomarkers, Tumor/metabolism , Breast Neoplasms/drug therapy , Breast Neoplasms/pathology , Cell Line, Tumor , Collagen/metabolism , Drug Combinations , Female , Gene Expression Regulation, Neoplastic/drug effects , Humans , Laminin/metabolism , Matrix Metalloproteinases/genetics , Neoplasm Invasiveness , Proteoglycans/metabolism , RNA, Messenger/genetics , RNA, Messenger/metabolism , Reverse Transcriptase Polymerase Chain Reaction , Tissue Inhibitor of Metalloproteinases/genetics
6.
Article in Chinese | WPRIM (Western Pacific) | ID: wpr-263063

ABSTRACT

<p><b>OBJECTIVE</b>To study the chemical constitutents of the 60% ethanol extract of the stems of Sambucus williamsii.</p><p><b>METHOD</b>Compounds were isolated and purified by Diaion D101, silica gel,Sephadex LH-20, ODS column chromatography and preparative HPLC. Their structures were identified by spectroscopic methods.</p><p><b>RESULT</b>Seven lignans were isolated and identified as erythro-guaiacylglycerol-beta-O-4'-sinapyl ether (1), 1-( 4'-hydroxy-3'-methoxyphenyl) -2- [4"-( 3-hydroxypropyl) -2", 6"-dimethoxyphenoxy] propane-1,3-diol (2), isolariciresinol (3), burselignan (4), lyoniresinol (5), 5-methoxy-isolariciresinol (6), cycloolivil (7).</p><p><b>CONCLUSION</b>All these compounds were obtained from this genus for the first time.</p>


Subject(s)
Anisoles , Chemistry , Antineoplastic Agents, Phytogenic , Chemistry , Chromatography, High Pressure Liquid , Lignans , Chemistry , Lignin , Chemistry , Microscopy , Naphthalenes , Chemistry , Naphthols , Chemistry , Plant Stems , Chemistry , Sambucus , Chemistry
7.
Plast Reconstr Surg ; 118(5): 1079-1086, 2006 Oct.
Article in English | MEDLINE | ID: mdl-17016170

ABSTRACT

BACKGROUND: The purpose of this study was to compare the local recurrence and distant metastasis of postmastectomy radiotherapy for breast cancer patients with and without immediate transverse rectus abdominis musculocutaneous (TRAM) flap reconstruction. METHODS: Between March of 1997 and October of 2001, 191 breast cancer patients received postmastectomy radiotherapy: 82 patients had TRAM flap reconstruction (TRAM flap group) and 109 patients did not (non-TRAM flap group). The mean radiation dose to the chest wall or entire TRAM flap, axillary area, and lower neck was 50 Gy (range, 48 to 54 Gy). The median follow-up period was 40 months. RESULTS: The percentages of chest wall recurrence were 3.7 percent (three of 82) in the TRAM flap group and 1.8 percent (two of 109) in the non-TRAM flap group (p = 0.653). The percentages of distant metastases were 12.2 percent (10 of 82) in the TRAM group and 15.6 percent (17 of 109) for the non-TRAM group (p = 0.67). The percentages of acute radiation dermatitis according to Radiation Therapy Oncology Group scoring criteria (TRAM flap group versus non-TRAM flap group) were as follows: grade I, 74 of 82 (90 percent) versus 93 of 109 (85 percent); grade II, seven of 82 (9 percent) versus 13 of 109 (12 percent); grade III, one of 82 (1 percent) versus three of 109 (3 percent) (p = 0.558). In the TRAM flap group, the increased percentage of fat necrosis was 8 percent. No flap loss was detected. CONCLUSIONS: There were no significant differences in the incidences of complication, locoregional recurrence, and distant metastasis between the TRAM flap and non-TRAM flap patients. The authors' results suggest that immediate TRAM flap reconstruction can be considered a feasible treatment for breast cancer patients requiring postmastectomy radiotherapy.


Subject(s)
Breast Neoplasms/pathology , Carcinoma/secondary , Mammaplasty , Mastectomy, Modified Radical , Neoplasm Recurrence, Local/epidemiology , Radiotherapy, Adjuvant , Surgical Flaps , Adult , Aged , Antineoplastic Agents, Hormonal/therapeutic use , Antineoplastic Agents, Phytogenic/therapeutic use , Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Breast Neoplasms/drug therapy , Breast Neoplasms/epidemiology , Breast Neoplasms/radiotherapy , Breast Neoplasms/surgery , Carcinoma/drug therapy , Carcinoma/epidemiology , Carcinoma/pathology , Carcinoma/radiotherapy , Carcinoma/surgery , Chemotherapy, Adjuvant , Combined Modality Therapy , Cyclophosphamide/administration & dosage , Doxorubicin/administration & dosage , Estrogen Antagonists/therapeutic use , Feasibility Studies , Female , Fluorouracil/administration & dosage , Follow-Up Studies , Humans , Middle Aged , Neoplasms, Hormone-Dependent/drug therapy , Neoplasms, Hormone-Dependent/pathology , Neoplasms, Hormone-Dependent/radiotherapy , Neoplasms, Hormone-Dependent/surgery , Neoplasms, Second Primary/epidemiology , Patient Satisfaction , Postoperative Complications/epidemiology , Postoperative Complications/etiology , Postoperative Complications/psychology , Radiodermatitis/etiology , Radiotherapy, Adjuvant/adverse effects , Retrospective Studies , Tamoxifen/therapeutic use , Taxoids/therapeutic use , Thoracic Wall/pathology , Thoracic Wall/radiation effects , Thoracic Wall/surgery , Time Factors , Treatment Outcome
8.
Cancer Lett ; 237(1): 109-14, 2006 Jun 08.
Article in English | MEDLINE | ID: mdl-16019138

ABSTRACT

The role of two adipocytokines, adiponectin and leptin, in Taiwanese breast cancer patients remains to be determined. In this study, we analyzed the correlations between the serum levels of adiponectin and leptin and the various clinicopathological parameters in 100 newly diagnosed, histologically confirmed breast cancer patients and 100 controls. We found serum levels were decreased significantly for adiponectin in the breast cancer patients, in comparison to controls (Student t-test, P=0.003), while serum levels were increased significantly for leptin in the breast cancer patients in comparison to controls (Student t-test, P=0.025). Leptin/adiponectin (L/A ratio) were increased significantly in the breast cancer patients, in comparison to controls (Student t-test, P=0.009). Among the clinicopathological parameters, estrogen receptor, progesterone receptor, HER2/neu, lymph node metastasis, tumor stage, and tumor grade all showed no effect on the serum levels of adiponectin and leptin. BMI was negatively and positively correlated to serum adiponectin and leptin levels, respectively (Spearman's correlation, r=-0.333 and 0.323, respectively; P<0.001 for both). Intriguingly, serum L/A ratio disclosed a positive correlation to tumor size (r=0.21, P=0.036). In summary, our results suggest that low serum adiponectin levels and high serum leptin levels are associated with an increased risk for breast cancer. Also, independent of the effect of BMI, the increased serum ratio of L/A may indicate the presence of aggressive breast cancers.


Subject(s)
Breast Neoplasms/blood , Leptin/blood , Adiponectin/blood , Adult , Age of Onset , Aged , Aged, 80 and over , Blood Glucose/analysis , Body Mass Index , Breast Neoplasms/pathology , Demography , Female , Humans , Middle Aged , Neoplasm Invasiveness , Taiwan
9.
Kaohsiung J Med Sci ; 19(10): 531-6, 2003 Oct.
Article in English | MEDLINE | ID: mdl-14620681

ABSTRACT

Desmoplastic small round cell tumor (DSRCT) is a rare and highly aggressive tumor usually involving the peritoneum. It occurs more commonly in young males and is characterized by distinctive clinical, histologic, and immunophenotypic features. The histogenesis of DSRCT remains unknown. Coexpression of epithelial, mesenchymal, and neural antigens in the same cell provides evidence that DSRCT may arise from a primitive pluripotent stem cell with divergent differentiation. Recently, according to cytogenetic studies, some authors have proposed that the divergent differentiation of DSRCT may be the result of the fusion of Ewing's sarcoma gene and Wilms' tumor suppressor gene. Clinically, an elevated serum CA 125 concentration is found in some patients with DSRCT. We present the case of a 29-year-old man with diffuse intra-abdominal DSRCT and elevated serum CA 125 concentration and briefly review the relevant literature.


Subject(s)
Abdominal Neoplasms/pathology , CA-125 Antigen/blood , Carcinoma, Small Cell/pathology , Abdominal Neoplasms/blood , Adult , Carcinoma, Small Cell/blood , Humans , Male , Oncogene Proteins, Fusion/genetics
SELECTION OF CITATIONS
SEARCH DETAIL